1. Regulation of Interleukin-23 Expression in Health and Disease
- Author
-
Stanislas Goriely and Iain Welsby
- Subjects
0301 basic medicine ,business.industry ,medicine.medical_treatment ,Interleukin ,Médecine pathologie humaine ,Inflammation ,Context (language use) ,Disease ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,Immune system ,Cytokine ,Psoriasis ,Immunology ,Immunologie ,medicine ,Interleukin 23 ,medicine.symptom ,business - Abstract
Interleukin (IL)-23 plays a central role in the orchestration of inflammatory responses. Produced by dendritic cells and macrophages, this cytokine promotes the protection of the host against mucosal pathogens through the induction of IL-17 and related cytokines by lymphoid cells. Preclinical disease models and association studies in humans have also clearly demonstrated the implication of IL-23 signalling pathway in inflammatory diseases. Indeed, this cytokine is now considered as a major therapeutic target in immune-based pathologies such as psoriasis, ankylosing spondylitis or Crohn's disease. Furthermore, in the context of inflammation-related cancer, IL-23 is thought to contribute to tumorigenesis and progression to metastatic disease. Herein, we review our current understanding of IL-23 regulation at the transcriptional and post-transcriptional levels. We discuss the relevance of these findings in the context of infection, chronic inflammation and cancer.
- Published
- 2016